These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 11465647)

  • 1. Effects of drug therapy on cardiac arrhythmias and ischemia in hypertensives with LVH.
    Novo S; Abrignani MG; Novo G; Nardi E; Dominguez LJ; Strano A; Barbagallo M
    Am J Hypertens; 2001 Jul; 14(7 Pt 1):637-43. PubMed ID: 11465647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased prevalence of cardiac arrhythmias and transient episodes of myocardial ischemia in hypertensives with left ventricular hypertrophy but without clinical history of coronary heart disease.
    Novo S; Barbagallo M; Abrignani MG; Nardi E; Di Maria GU; Longo B; Mistretta A; Strano A
    Am J Hypertens; 1997 Aug; 10(8):843-51. PubMed ID: 9270078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Losartan controlled blood pressure and reduced left ventricular hypertrophy but did not alter arrhythmias in hypertensive men with preserved systolic function.
    Zakynthinos E; Pierrutsakos Ch; Daniil Z; Papadogiannis D
    Angiology; 2005; 56(4):439-49. PubMed ID: 16079926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Greater regression of electrocardiographic left ventricular hypertrophy during hydrochlorothiazide therapy in hypertensive patients.
    Okin PM; Hille DA; Kjeldsen SE; Lindholm LH; Edelman JM; Dahlöf B; Devereux RB
    Am J Hypertens; 2010 Jul; 23(7):786-93. PubMed ID: 20395941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of spirapril, isradipine, or combination in hypertensive patients with left ventricular hypertrophy: effects on LVH regression and arrhythmogenic propensity.
    Manolis AJ; Beldekos D; Handanis S; Haralabidis G; Hatzissavas J; Foussas S; Cokkinos DV; Bresnahan M; Gavras I; Gavras H
    Am J Hypertens; 1998 Jun; 11(6 Pt 1):640-8. PubMed ID: 9657622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V; Devereux RB
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effects of candesartan and enalapril on left ventricular hypertrophy in patients with essential hypertension: the candesartan assessment in the treatment of cardiac hypertrophy (CATCH) study.
    Cuspidi C; Muiesan ML; Valagussa L; Salvetti M; Di Biagio C; Agabiti-Rosei E; Magnani B; Zanchetti A;
    J Hypertens; 2002 Nov; 20(11):2293-300. PubMed ID: 12409969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study.
    Pitt B; Reichek N; Willenbrock R; Zannad F; Phillips RA; Roniker B; Kleiman J; Krause S; Burns D; Williams GH
    Circulation; 2003 Oct; 108(15):1831-8. PubMed ID: 14517164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ventricular arrhythmias in hypertension: in which patients do they occur?
    Mayet J; Shahi M; Poulter NR; Sever PS; Thom SA; Foale RA
    J Hypertens; 1995 Feb; 13(2):269-76. PubMed ID: 7615959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of antihypertensive therapy on left ventricular hypertrophy and on its pathophysiologic sequelae.
    Messerli FH
    Blood Press Suppl; 1992; 1():35-6; discussion 37. PubMed ID: 1343271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regression of left ventricular hypertrophy in hypertensive patients treated with indapamide SR 1.5 mg versus enalapril 20 mg: the LIVE study.
    Gosse P; Sheridan DJ; Zannad F; Dubourg O; Guéret P; Karpov Y; de Leeuw PW; Palma-Gamiz JL; Pessina A; Motz W; Degaute JP; Chastang C
    J Hypertens; 2000 Oct; 18(10):1465-75. PubMed ID: 11057435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial.
    Devereux RB; Dahlöf B; Gerdts E; Boman K; Nieminen MS; Papademetriou V; Rokkedal J; Harris KE; Edelman JM; Wachtell K
    Circulation; 2004 Sep; 110(11):1456-62. PubMed ID: 15326072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of celiprolol on cardiac hypertrophy in hypertension.
    Haneda T; Ogawa Y; Kato J; Matsuhashi H; Morimoto H; Honda H; Takenaka T; Tanazawa S; Kataoka R; Kikuchi K
    Hypertens Res; 2000 Sep; 23(5):467-74. PubMed ID: 11016801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indapamide reduces hypertensive left ventricular hypertrophy: an international multicenter study.
    Senior R; Imbs JL; Bory M; Amabile G; Denis B; Zannad F; De Luca N; Marchegiano R; Lahiri A; Raftery EB
    J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S106-10. PubMed ID: 7508055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study.
    Okin PM; Devereux RB; Jern S; Kjeldsen SE; Julius S; Nieminen MS; Snapinn S; Harris KE; Aurup P; Edelman JM; Dahlof B;
    Circulation; 2003 Aug; 108(6):684-90. PubMed ID: 12885747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Arrhythmia risk and noninvasive markers in hypertensive left ventricular hypertrophy].
    Akdeniz B; Güneri S; Badak O; Aslan O; Tamci B
    Anadolu Kardiyol Derg; 2002 Jun; 2(2):121-9; AXVII. PubMed ID: 12134537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Arrhythmogenicity in left ventricular hypertrophy in mild to moderate arterial hypertension].
    Franchi F; Michelucci A; Padeletti L; Monopoli A; Fabbri G; Cersosimo RM; Mezzani A
    G Ital Cardiol; 1992 Aug; 22(8):905-18. PubMed ID: 1478391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of renin-angiotensin system blockers on left ventricular hypertrophy and biochemical markers of collagen balance in patients with hypertensive hypertrophy].
    Ovchinnikov AG; Serbul VM; Ageev FT
    Ter Arkh; 2009; 81(5):64-71. PubMed ID: 19537590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of diuretic therapy on ventricular arrhythmias in hypertensive patients with or without left ventricular hypertrophy.
    Papademetriou V; Price M; Notargiacomo A; Gottdiener J; Fletcher RD; Freis ED
    Am Heart J; 1985 Sep; 110(3):595-9. PubMed ID: 2412429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Myocardial structure and study of arrhythmias during ambulatory electrocardiographic monitoring in mild essential hypertension].
    Pose-Reino A; González-Juanatey JR; Pastor C; Méndez I; Estévez JC; Cabezas-Cerrato J
    Med Clin (Barc); 1996 Jan; 106(1):7-10. PubMed ID: 8750534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.